239 related articles for article (PubMed ID: 9250550)
1. Symptomatic cardiotoxicity associated with 5-fluorouracil.
Meyer CC; Calis KA; Burke LB; Walawander CA; Grasela TH
Pharmacotherapy; 1997; 17(4):729-36. PubMed ID: 9250550
[TBL] [Abstract][Full Text] [Related]
2. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.
Cianci G; Morelli MF; Cannita K; Morese R; Ricevuto E; Di Rocco ZC; Porzio G; Lanfiuti Baldi P; Ficorella C
Br J Cancer; 2003 May; 88(10):1507-9. PubMed ID: 12771913
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.
Meydan N; Kundak I; Yavuzsen T; Oztop I; Barutca S; Yilmaz U; Alakavuklar MN
Jpn J Clin Oncol; 2005 May; 35(5):265-70. PubMed ID: 15855175
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity of 5-fluorouracil.
Collins C; Weiden PL
Cancer Treat Rep; 1987; 71(7-8):733-6. PubMed ID: 3300968
[TBL] [Abstract][Full Text] [Related]
6. Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine.
Jensen SA; Sørensen JB
Cancer Chemother Pharmacol; 2006 Oct; 58(4):487-93. PubMed ID: 16418875
[TBL] [Abstract][Full Text] [Related]
7. Acute heart failure after treatment with 5-fluorouracil.
Georgieva S; Kinova E; Iordanov V; Gudev A; Tzekova V; Velikova M
J BUON; 2007; 12(1):113-6. PubMed ID: 17436411
[TBL] [Abstract][Full Text] [Related]
8. [Cardiotoxicity of 5-fluorouracil].
Pan L; Yang X; Song H
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):86-9. PubMed ID: 8758800
[TBL] [Abstract][Full Text] [Related]
9. [Cardiotoxicity of 5-fluorouracil: report of 6 cases].
Timour Q; Lombard-Bohas C; Slim R; Barel C; Bui-Xuan B; Tabib A; Bricca G; Malonne H; Vial T; Iordescu D; Descotes J
Therapie; 2002; 57(3):302-6. PubMed ID: 12422546
[TBL] [Abstract][Full Text] [Related]
10. [5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy?].
Maurer U; Härle M; Jungius KP
Strahlenther Onkol; 1996 May; 172(5):257-9. PubMed ID: 8633257
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.
Tsibiribi P; Descotes J; Lombard-Bohas C; Barel C; Bui-Xuan B; Belkhiria M; Tabib A; Timour Q
Bull Cancer; 2006 Mar; 93(3):E27-30. PubMed ID: 16567310
[TBL] [Abstract][Full Text] [Related]
12. [Acute cardiac toxicity of 5-fluorouracil: pharmacokinetic correlation].
Gamelin E; Gamelin L; Larra F; Turcant A; Alain P; Maillart P; Allain YM; Minier JF; Dubin J
Bull Cancer; 1991; 78(12):1147-53. PubMed ID: 1786427
[TBL] [Abstract][Full Text] [Related]
13. Fluoropyrimidine-associated cardiotoxicity: revisited.
Saif MW; Shah MM; Shah AR
Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247
[TBL] [Abstract][Full Text] [Related]
14. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
Shaib W; Lee V; Saif MW
In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
[TBL] [Abstract][Full Text] [Related]
15. [Multicenter prospective study of cardiac accidents during treatments with 5-FU].
Sorbette F; Simon I; Bonneterre J; Clavel M; David M; Degardin M; Labat JP; Pinot I; Thyss A; Vignoud J
Therapie; 1992; 47(5):371-3. PubMed ID: 1299974
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
17. [Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].
de Forni M; Bugat R; Sorbette F; Delay M; Bachaud JM; Chevreau C
Bull Cancer; 1990; 77(5):429-38. PubMed ID: 2205312
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity.
Porta C; Moroni M; Ferrari S; Nastasi G
Neoplasma; 1998; 45(2):81-2. PubMed ID: 9687887
[TBL] [Abstract][Full Text] [Related]
19. Influence of high-dose leucovorin and 5-fluorouracil chemotherapy regimen on P wave duration and dispersion.
Ceyhan C; Meydan N; Barutca S; Tekten T; Onbasili AO; Ozturk B; Unal S; Bayrak I
J Clin Pharm Ther; 2004 Jun; 29(3):267-71. PubMed ID: 15153089
[TBL] [Abstract][Full Text] [Related]
20. A case of acute myocardial infarction during 5-fluorouracil infusion.
Canale ML; Camerini A; Stroppa S; Porta RP; Caravelli P; Mariani M; Balbarini A; Ricci S
J Cardiovasc Med (Hagerstown); 2006 Nov; 7(11):835-7. PubMed ID: 17060812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
